Health Care/Hospital
MediTrust Health Shares Insights at Hong Kong Fintech Week: AI Pragmatically Reshaping Cross-Border Healthcare Payments in the Greater Bay Area
HONG KONG, Nov. 6, 2025 /PRNewswire/ -- MediTrust Health, the largest innovative healthcare payor platform inChina, delivered key insights recently at the HealthTech Forum of "Hong Kong FinTech Week 2025."Seth Zhang, Founder and CEO of MediTrust Health, stated that Artificial Intelligence (AI) i...
2025-11-06 14:53
1422
Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy
Lunai Bioworks Announces Publication of Second-Generation Allogeneic Dendritic Cell Therapy Platform in the journal "Vaccines". LOS ANGELES, Nov. 6, 2025 /PRNewswire/ -- Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense company, has announced a major scientific breakthro...
2025-11-06 14:11
1439
THE ADECCO GROUP Q3 2025 RESULTS
AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss Exchange Strong share gains, good growth and improved profit margin ZURICH, Nov. 6, 2025 /PRNewswire/ -- HIGHLIGHTS * Further strong market share gains, Group +375 bps and Adecco +300 bps * Group revenues +3.4% yoy, and +3...
2025-11-06 13:45
1043
Alphamab Oncology Showcases Cutting-edge Breakthroughs and Innovative Achievements at the 16th World ADC San Diego
SUZHOU, China, Nov. 6, 2025 /PRNewswire/ -- The 16th World ADC San Diego, held from November 3–6, 2025, brought together industry leaders inSan Diego, USA. Dr. Ting Xu, Founder, Chairman, and CEO of Alphamab Oncology, was invited to deliver a presentation titled "JSKN021: EGFR/HER3 Targeted Dual-...
2025-11-06 12:05
1518
The 2025 Chinese Congress on Holistic Integrative Oncology (CCHIO) will be held in Kunming, presenting a new landscape of integrated cancer prevention and treatment from a global perspective.
KUNMING, China, Nov. 5, 2025 /PRNewswire/ -- From November 6 to 9, 2025, the highly anticipated 2025 CCHIO will be grandly held in Kunming, the "Spring City". Hosted by the Chinese Anti-Cancer Association and the Secretariat of the Tengchong Scientists Forum Organizing Committee, co-hosted by the...
2025-11-06 10:58
1132
New Regional Certifications to Boost Healthcare Training Standards Across Southeast Asia
* Two new specially designed certification programmes will train doctors, nurses and technical specialists across the region in simulation-based medical education. SINGAPORE, Nov. 6, 2025 /PRNewswire/ -- The first healthcare simulation certification programmes designed specifically for Southeas...
2025-11-06 10:13
1170
The World's First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia
CorrectSequence Therapeutics' CS-121 Completed Dosing of First Chylomicronemia
Patient, Demonstrating Excellent Safety and Significant Efficacy
SHANGHAI, Nov. 6, 2025 /PRNewswire/ -- On November 6, 2025, Shanghai,
China, CorrectSequence Therapeutics Co., Ltd. (Correctseq
2025-11-06 08:00
1337
Natural Field will Launch "Ashwagandha White Paper" at FTA Forum in Hangzhou
HANGZHOU, China, Nov. 5, 2025 /PRNewswire/ -- Natural Field, a leading Chinese supplier of botanical and functional ingredients, is set to release its highly anticipatedAshwagandha White Paper at the prestigious Food Technology and Application (FTA) Forum in Hangzhou. The forum, recognized as one...
2025-11-05 23:00
1122
Andor Health's Agentic AI Platform, ThinkAndor®, Receives Frost & Sullivan's 2025 North American Transformational Innovation Leadership Recognition for Excellence in Acute Care Virtual Health
Recognized for its transformational innovation and customer impact in driving
the evolution of acute care virtual health through advanced, agentic AI-powered
collaboration solutions.
SAN ANTONIO, Nov. 5, 2025 /PRNewswire/ -- Frost & Sullivan
2025-11-05 22:30
2151
Milliken & Company Recognized with 2025 EcoVadis Gold Rating, Placing in Top 5% Worldwide
SPARTANBURG, S.C., Nov. 5, 2025 /PRNewswire/ -- Milliken & Company, a global leader in manufacturing and material science, has earned a gold rating in the 2025 EcoVadis assessment for the fourth consecutive year, placing the company among the top 5% of more than 150,000 organizations evaluated ar...
2025-11-05 21:50
1268
BioDlink Congratulates Lepu Biopharma on Securing Approval for the World's First Approved EGFR-Targeted ADC
* BioDlink helps Lepu Biopharma win China's marketing approval for EGFR-targeted ADC treating recurrent or metastatic nasopharyngeal carcinoma * This Becotatug Vedotin injection approval is BioDlink's first commercial ADC manufacturing initiative worldwide, validating its complex biologics co...
2025-11-05 21:00
1495
IDT Biologika Accelerates Global CDMO Expansion Manufacturing capabilities highlighted through consecutive participation in WVC, CPHI and BIO-Europe 2025
* Showcased end-to-end, customized manufacturing capabilities covering vaccines, gene and immune therapeutics * Strengthening global CDMO strategy through strategic synergy with SK bioscience * Sustainable growth expected, backed by European commercial manufacturing infrastructure and regul...
2025-11-05 21:00
1804
Nona Biosciences Announces Expansion of Collaboration with Umoja Biopharma to Advance In Vivo CAR-T Cell Therapies
CAMBRIDGE, Mass., Nov. 5, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I™), today announced an evaluation and license agreement with Umoja Biopharma ("Umoja"), the clinical-stage leader of in vivo cell therapies that...
2025-11-05 20:07
1104
HanchorBio Presents Preclinical Data on HCB301 at SITC 2025
HCB301 is a first-in-class tri-specific immunotherapy targeting SIRPα-CD47, PD-1/PD-L1, and TGFβ; it shows potent macrophage activation, T-cell restoration, and tumor microenvironment remodeling in preclinical solid tumor models. TAIPEI, SHANGHAI, and SAN FRANCISCO, Nov. 5, 2025 /PRNewswire/ -- ...
2025-11-05 20:00
2733
XtalPi Subsidiary Ailux Announces Strategic Collaboration with Lilly to Advance Bispecific Antibody Development
SHANGHAI, Nov. 5, 2025 /PRNewswire/ -- Ailux, an innovator in AI-powered biologics and a wholly owned subsidiary of XtalPi (2228.HK), a global leader in AI drug discovery, today announced a strategic platform-based collaboration with Eli Lilly and Company ("Lilly") to accelerate the discovery and...
2025-11-05 18:00
1355
SingHealth Duke-NUS Launches Two New Global Health Centres to Advance Allied Health and Pharmacy Practices in Asia
* The Centre for Global Allied Health and Centre for Global Pharmacy will advance global health collaboration and capacity building, with a focus on strengthening allied health and pharmacy practices acrossAsia. * Both centres build on a legacy of more than 120 global health projects led by S...
2025-11-05 15:43
1068
KLN Appointed by Ego Pharmaceuticals as 4PL Partner in Hong Kong Strategic Collaboration to Deliver End-to-End Healthcare Supply Chain Solutions
HONG KONG, Nov. 5, 2025 /PRNewswire/ -- KLN Logistics Group Limited ('KLN'; Stock Code 0636.HK) is pleased to announce the appointment of its pharmaceutical arm, KLN Pharma (Hong Kong) Limited ('KLN Pharma'), as the fourth-party logistics (4PL) service provider for Australian skincare brand Ego ...
2025-11-05 13:42
1031
NEC Drives the Future of Smart Living By Elevating Health, Cybersecurity, and Disaster Resilience at Thailand Smart City Expo 2025
BANGKOK, Nov. 5, 2025 /PRNewswire/ -- NEC Corporation (Thailand) Ltd. reaffirms its commitment to creating social value forThailand by empowering cities, people, and businesses with advanced technology. Guided by NEC's global purpose to "create the social values ofsafety, security, fairness, and e...
2025-11-05 09:19
1955
Zepp Health Corporation Reports Third Quarter 2025 Unaudited Financial Results
MILPITAS, Calif., Nov. 4, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today announced its unaudited financial results for the third quarter of 2025. Third Quarter 2025 Financial and Operating Highlights: * Revenue reached US$75.8 million, representing 78...
2025-11-05 09:15
2490
Ascletis Presents Full Analysis of Phase Ib Study of ASC30 Oral Tablet, Phase Ib Study of ASC30 Injection, and Preclinical Study of Combination of ASC31 and ASC47 at ObesityWeek® 2025
-Positive data from Phase Ib study of ASC30 oral tablet demonstrated up to 6.5% placebo-adjusted mean body weight reduction; safe and well tolerated with only mild-to-moderate gastrointestinal (GI) adverse events (AEs) across all multiple ascending dose (MAD) cohorts. -Phase Ib study data of ASC...
2025-11-05 08:10
1655
Week's Top Stories
Most Reposted
Marina Bay precinct partners UOB, Marina Bay Sands and Singapore Tourism Board, together with Disney Cruise Line, to illuminate Singapore's skyline with a fireworks sky show
[Picked up by 328 media titles]
2026-02-19 14:30
Never Miss a Message: Agoda's Customer Support Now Travels With You
[Picked up by 322 media titles]
2026-02-24 12:00
NextFin Asia: A New Dedicated Fund for the Catapult: Inclusion SE Asia Program to Further Scale Inclusive Finance Fintechs in ASEAN
[Picked up by 311 media titles]
2026-02-23 08:00
Klook and Osaka Convention & Tourism Bureau sign MoU to advance inbound tourism and foster socio-economic development throughout Osaka Prefecture
[Picked up by 290 media titles]
2026-02-24 16:13
Vitafoods Asia 2026 Expands by 30%: A Bigger, More Dynamic Trade Event with Exciting New Features & Increased International Participation
[Picked up by 288 media titles]
2026-02-23 10:09